CSIMarket
 


Allergan plc  (AGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AGN's Revenue Growth by Quarter and Year

Allergan Plc's Revenue results by quarter and year




AGN Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 4,351.00 4,079.70 4,326.10
III Quarter September - 4,050.70 3,911.40 4,034.30
II Quarter June - 4,090.10 4,124.20 4,007.40
I Quarter March 3,604.40 3,597.10 3,672.10 3,572.90
FY   3,604.40 16,088.90 15,787.40 15,940.70



AGN Revenue first quarter 2020 Y/Y Growth Comment
Allergan plc reported Revenue growth of 0.2% year on year in the first quarter, to $ 3,604.40 millions, this is lower than Allergan Plc's recent average Revenue increase of 17.86%.

Looking into first quarter results within Biotechnology & Drugs industry 63 other companies have achieved higher Revenue growth. While Allergan Plc' s Revenue increase of 0.2% ranks overall at the positon no. 1855 in the first quarter.




AGN Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 6.65 % -5.7 % 24.75 %
III Quarter September - 3.56 % -3.05 % 11.38 %
II Quarter June - -0.83 % 2.91 % 8.75 %
I Quarter March 0.2 % -2.04 % 2.78 % -5.87 %
FY   - 1.91 % -0.96 % 9.4 %

Financial Statements
Allergan Plc's first quarter 2020 Revenue $ 3,604.40 millions AGN's Income Statement
Allergan Plc's first quarter 2019 Revenue $ 3,597.10 millions Quarterly AGN's Income Statement
New: More AGN's historic Revenue Growth >>


AGN Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 7.41 % 4.3 % 7.23 %
III Quarter September - -0.96 % -5.16 % 0.67 %
II Quarter June - 13.71 % 12.31 % 12.16 %
I Quarter March -17.16 % -11.83 % -15.12 % 3.03 %
FY (Year on Year)   - 1.91 % -0.96 % 9.4 %




Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #64
Healthcare Sector #331
Overall #1855

Revenue Y/Y Growth Statistics
High Average Low
208.71 % 17.86 % -35.97 %
(Jun 30 2015)   (Jun 30 2016)
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #64
Healthcare Sector #331
Overall #1855
Revenue Y/Y Growth Statistics
High Average Low
208.71 % 17.86 % -35.97 %
(Jun 30 2015)   (Jun 30 2016)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Allergan Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
78.29 % 2.47 % -40.77 %
(Dec 31 2013)  


AGN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Allergan Plc disclosed fall in Revenue from the previous quarter by -17.16% to $ 3,604.40 millions, from $ 4,351.00 millions achived in the previous reporting period.

If you analyse present shortcoming at the I. Quarter, you should take into consideration, that commonly I. Quarter Revenue occur softer in contrast to the quarter before

Within Biotechnology & Drugs industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Allergan Plc's Revenue growth quarter on quarter, overall rank is 2857.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #81
Healthcare Sector #390
Overall #2857
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #81
Healthcare Sector #390
Overall #2857
Revenue Q/Q Growth Statistics
High Average Low
78.29 % 2.47 % -40.77 %
(Dec 31 2013)  


AGN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Allergan Plc realized fall in Revenue from the forth quarter by -17.16% to $ 3,604.40 millions, from $ 4,351.00 millions achived in the previous reporting period.

But that's not important concern, as Revenue generally seem to dip in the I. Quarter.

Within Biotechnology & Drugs industry 80 other companies have achieved higher Revenue quarter on quarter growth. While Allergan Plc's Revenue growth quarter on quarter, overall rank is 2857.


Allergan Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 16,096.20 $ 16,088.90 $ 15,817.60 $ 15,678.30 $ 15,712.40
Y / Y Revenue Growth (TTM) 2.44 % 1.91 % -1.35 % -2.96 % -2.04 %
Year on Year Revenue Growth Overall Ranking # 1845 # 1468 # 1929 # 2665 # 2451
Seqeuential Revenue Change (TTM) 0.05 % 1.72 % 0.89 % -0.22 % -0.48 %
Seq. Revenue Growth (TTM) Overall Ranking # 1854 # 1625 # 1670 # 2371 # 2227




Cumulative Revenue growth Comment
Although Allergan Plc's Annual Revenue growth year on year were below company's average 14.61% , Revenue announced in the Mar 31 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.44% year on year, from 1.91% in Dec 31 2019.

In the Healthcare sector 279 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1468 to 1845.

Revenue TTM Q/Q Growth Statistics
High Average Low
78.23 %
3.66 %
-10.97 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 64
Healthcare Sector # 280
Overall # 1845

Revenue TTM Y/Y Growth Statistics
High Average Low
160.67 %
14.61 %
-23.95 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 64
Sector # 331
S&P 500 # 1854
Cumulative Revenue growth Comment
Although Allergan Plc's Annual Revenue growth year on year were below company's average 14.61% , Revenue announced in the Mar 31 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.44% year on year, from 1.91% in Dec 31 2019.

In the Healthcare sector 279 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1468 to 1845.

Revenue TTM Q/Q Growth Statistics
High Average Low
78.23 %
3.66 %
-10.97 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 64
Healthcare Sector # 280
Overall # 1845

Revenue TTM Y/Y Growth Statistics
High Average Low
160.67 %
14.61 %
-23.95 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 64
Sector # 331
S&P 500 # 1854




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AGN's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AGN's Competitors
Revenue Growth for Allergan Plc's Suppliers
Revenue Growth for AGN's Customers

You may also want to know
AGN's Annual Growth Rates AGN's Profitability Ratios AGN's Asset Turnover Ratio AGN's Dividend Growth
AGN's Roe AGN's Valuation Ratios AGN's Financial Strength Ratios AGN's Dividend Payout Ratio
AGN's Roa AGN's Inventory Turnover Ratio AGN's Growth Rates AGN's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Allergan plc0.20%$ 0.203 millions
Lifevantage Corp0.12%$ 0.116 millions
Vycor Medical Inc0.11%$ 0.110 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EBTC's Profile

Stock Price

EBTC's Financials

Business Description

Fundamentals

Charts & Quotes

EBTC's News

Suppliers

EBTC's Competitors

Customers & Markets

Economic Indicators

EBTC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071